Tiago Lopes: Can AI Predict Immune Reactions of New Drugs?
Tiago Lopes, Research Scientist at Heidelberg University, shared on LinkedIn:
”Can AI predict immune reactions of new drugs? Yes.
Its not perfect, but it is very good.
In this paper fresh from the oven, my colleagues from Japan and I present a new coagulation factor 8 (FVIII), designed and tested as a gene therapy.
People who have a defect in this gene live with hemophilia, a coagulation problem that requires constant injections; and even then, they are at constant risk of joint, muscle and other hemorrhages.
The treatment is super expensive, and still has a major problem of triggering an immune reaction; it renders the treatment ineffective, which without a doubt, sucks.
Here, a comprehensive and reliable AI prediction was made, showing this FVIII variant is not worse than the “original” protein that people have.
Hope. This is the word for patients and their families.
We are working around the clock to have your kids playing soccer without worrying about not walking the next day.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers